| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| F794434 | MACKLIN | 氟非那嗪盐酸盐 | 10mM in DMSO | 185元/1ml; | 咨询 |
|
| F838502 | MACKLIN | 氟非那嗪盐酸盐 | 98% | 128元/50mg; 380元/250mg; 1240元/1g; | 咨询 |
|
| F1240 | TCI | Fluphenazine Dihydrochloride | >98.0%(HPLC) | 725元/1G; 2450元/5G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC) | | 分子式/分子量 | C22H26F3N3OS・2HCl = 510.44 | | 外观与形状(20℃) | 固体 | | 包装和容器 | 1G-带有塑料内管的玻璃瓶 (查看图片) | | Reaxys-RN | 3830953 | | Merck Index (14) | 4189 | | MDL编号 | MFCD00055212 |
技术规格 | Appearance | White to Light yellow powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 97.0 % | | Melting point | 225.0 to 231.0 ℃ |
物性(参考值) | 熔点 | 227 ℃ | | 最大吸收波长 | 311(MeOH) nm | | 水溶性 | 可溶 |
安全信息 | 图形或危害标志 |   | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。 H360 : 可能对生育能力或胎儿造成伤害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| PHR1792 | Supelco | Fluphenazine Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material | 1568.52元/1 G; | 咨询 |
产品说明 一般描述 药物二级标准品CRM,为制药行业QC实验室及生产质量控制和研发,提供了一种方便、高性价比且符合相关法规的替代方案。 生化/生理作用 D1/D2多巴胺受体拮抗剂;吩噻嗪类抗精神病药;H1组胺受体拮抗剂。 分析说明 这些二级标准品可溯源到USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 欲查看此物质的分析证书样本,请在下面的对话框中输入LRAA8814。这只是一个示例证书,可能与您收到的批次不符。 基本信息 | 经验(实验)分子式 | C22H26F3N3OS · 2HCl | | 分子量 | 510.44 | | EC 号 | 205-674-1 | | MDL编号 | MFCD00055212 | | PubChem化学物质编号 | 329823616 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | 形式 | powder | | CofA | current certificate can be downloaded | | 包装 | pkg of 1 g | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 药典可追溯性 | traceable to BP 167 traceable to PhEur F0280000 traceable to USP 1282004 | | 储存温度 | 2-30℃ | | SMILES string | Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 | | InChI | 1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H | | InChI key | MBHNWCYEGXQEIT-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H360 | | 预防措施声明 | P201 - P301 + P310 + P330 | | 危险分类 | Acute Tox. 3 Oral - Repr. 1A | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| F0280000 | | Fluphenazine Dihydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 D1/D2多巴胺受体拮抗剂;吩噻嗪类抗精神病药;H1组胺受体拮抗剂。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H26F3N3OS · 2HCl | | 分子量 | 510.44 | | MDL编号 | MFCD00055212 | | PubChem化学物质编号 | 329799648 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 | | InChI | 1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H | | InChI key | MBHNWCYEGXQEIT-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H360 | | 预防措施声明 | P201 - P301 + P310 + P330 | | 危险分类 | Acute Tox. 3 Oral - Repr. 1A | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP167 | | Fluphenazine Hydrochloride | British Pharmacopoeia (BP) Reference Standard | 1916.08元/100 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 D1/D2多巴胺受体拮抗剂;吩噻嗪类抗精神病药;H1组胺受体拮抗剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H26F3N3OS · 2HCl | | 分子量 | 510.44 | | MDL编号 | MFCD00055212 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 | | InChI | 1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H | | InChI key | MBHNWCYEGXQEIT-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H360 | | 预防措施声明 | P201 - P264 - P280 - P301 + P310 + P330 - P308 + P313 - P501 | | 危险分类 | Acute Tox. 3 Oral - Repr. 1A | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1282004 | USP | Fluphenazine Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 2633.96元/125 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 D1/D2多巴胺受体拮抗剂;吩噻嗪类抗精神病药;H1组胺受体拮抗剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C22H26F3N3OS · 2HCl | | 分子量 | 510.44 | | MDL编号 | MFCD00055212 | | PubChem化学物质编号 | 329749886 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 | | InChI | 1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H | | InChI key | MBHNWCYEGXQEIT-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H360 | | 预防措施声明 | P201 - P280 - P301 + P330 + P331 + P310 - P308 + P313 | | 危险分类 | Acute Tox. 3 Oral - Repr. 1A | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 547243 | Fluorochem | Fluphenazine Dihydrochloride | 98+% | 594元/250mg; 1188元/1g; 3740元/5g; | 咨询 |
基本信息 | CAS Number | 146-56-5 | | MDL Number | MFCD00055212 |
|